Medifront Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Medifront Pharmaceuticals Private Limited

Medifront Pharmaceuticals Private Limited, a struck off private limited company, was established on 05 November 2019 in Hyderabad, Telangana, India. Engaging in other services within the business services sector, it holds CIN: U74999TG2019PTC136617. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vivek Maheshkumar Agrawal (Director), Radha Dheeraj Agrawal (Director). Past directors included Vivek Maheshkumar Agrawal. It is based at 3-53-133, New Ga R.K.Puram, Tirumalgi, Hyderabad, Telangana, 500056.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2019PTC136617

  • Registration Number

    136617

  • Incorporation Date

    05 November 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 3 Months
Company report

Medifront Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medifront Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medifront Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vivek Maheshkumar Agrawal Director 05 Nov 2019 Current
Radha Dheeraj Agrawal Director 05 Nov 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medifront Pharmaceuticals.

Enhance accessibility to Medifront Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medifront Pharmaceuticals revenue growth over time
Medifront Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medifront Pharmaceuticals?

Unlock access to Medifront Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medifront Pharmaceuticals?

Unlock and access historical data on people associated with Medifront Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medifront Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medifront Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medifront Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Vivek Maheshkumar Agrawal was appointed as a Director was appointed as a Director on 05 Nov 2019 & has been associated with this company since 6 years 3 months . was completed.

  • Director Appointment

    Radha Dheeraj Agrawal was appointed as a Director was appointed as a Director on 05 Nov 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.

  • Company Incorporation

    The activity Medifront Pharmaceuticals Private Limited was registered on 05 Nov 2019 with Roc Hyderabad & aged 6 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medifront Pharmaceuticals Private Limited?

The CIN of Medifront Pharmaceuticals Private Limited is U74999TG2019PTC136617.

Where is Medifront Pharmaceuticals Private Limited headquartered?

Medifront Pharmaceuticals Private Limited is headquartered at 3-53-133, New Ga R.K.Puram, Tirumalgi, Hyderabad, Telangana, 500056.

When was Medifront Pharmaceuticals Private Limited incorporated?

Medifront Pharmaceuticals Private Limited was incorporated on 05 November 2019.

Who are the current directors of Medifront Pharmaceuticals Private Limited?

The current directors of Medifront Pharmaceuticals Private Limited are

What is the primary industry of Medifront Pharmaceuticals Private Limited?

The primary industry of Medifront Pharmaceuticals Private Limited is Business Services.

Is Medifront Pharmaceuticals Private Limited a listed company?

Medifront Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Medifront Pharmaceuticals Private Limited?

The authorized capital of Medifront Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available